Scientific corner

Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study

Takayuki Yamamoto 1, Satoru Umegae, Koichi Matsumoto, J Gastroenterol 2011 Aug;46(8):1003-9.

This is the first report on daily GMA in the treatment of patients with UC. Daily GMA was safe and well tolerated without serious AE. Furthermore, daily GMA was associated with rapid improvement of clinical symptoms in patients with moderately active UC. However, controlled trials are warranted to assess a definite efficacy for daily GMA therapy.

https://pubmed.ncbi.nlm.nih.gov/21681409/

Clinical remission / daily / feasibility study / prospective / symptoms efficay /

Contact UsFor more information

Contact Us